SANDOZ LISDEXAMFETAMINE CAPSULES

Sandoz Canada, Inc.🇨🇦 Health Canada

Approval Id: 16fcf026716d73da
Drug Approval Canada Name: SANDOZ LISDEXAMFETAMINE CAPSULES
Product Name: SANDOZ LISDEXAMFETAMINE CAPSULES
Status: Marketed
Status Date: 2024-06-04
Original Market Date: 2024-06-04
Din: 02546280
Drug Class: Human
Dosage Form: Capsule
Route Of Administration: Oral
Schedule: Schedule G (CDSA I)
Ahfs: 28:20.04
Atc Original: N06BA12 LISDEXAMFETAMINE
Atc Name: n 06 ba 12
Aig Number: 0152536002
Company Name: Sandoz Canada, Inc.
Company Address: 4600 Rue Armand-Frappier, Saint-Hubert, Quebec, Canada, J3Z 1G5
Company Detail Path: /organization/sandoz-canada-inc

LISDEXAMFETAMINE DIMESYLATE

50 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

16fcf026716d73da

Type

Standard